The TRICURE EFS Study (TRICURE EFS)
The TRICURE EFS TRiCares Topaz Transfemoral TRICUspid Heart Valve REplacement System Early Feasibility Study
Sponsor: TRiCares
Listed as NCT06506942, this observational or N/A phase trial focuses on Cardiovascular Diseases and Heart Valve Diseases and remains actively recruiting participants. Sponsored by TRiCares, it has been updated 9 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Study Description(click to expand)The study is a multi-center, prospective single arm study designed to evaluate the safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System.
The study is a multi-center, prospective single arm study designed to evaluate the safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System.
Status Flow
Change History
9 versions recorded-
Apr 16, 2026 — Present [daily]
Recruiting
Phase: NA → None
-
Jan 2026 — Apr 2026 [monthly]
Recruiting NA
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
May 2025 — Sep 2025 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Mar 2025 — May 2025 [monthly]
Withheld
Status: Recruiting → Withheld · Phase: NA → None
▶ Show 4 earlier versions
-
Dec 2024 — Mar 2025 [monthly]
Recruiting NA
-
Oct 2024 — Dec 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Contact Information
- TRiCares
For direct contact, visit the study record on ClinicalTrials.gov .